Associations

Pharmacy advocates will urge members of Congress to act on legislative priorities that benefit Americans and the pharmacies on which they rely.

The roundtable focused on anticompetitive PBM practices that drive up drug costs for American families, limit patient choice and squeeze community pharmacies.

Senate Bill 688 lifts the annual purchasing limits for common over-the-counter cold and allergy medications containing PSE.

Next week, on NACDS RxIMPACT Day on Capitol Hill, NACDS members and pharmacy advocates will push for PBM reform in-person to Congress and the Biden Administration.

The Council for Responsible Nutrition will host its annual conference, Convergence ’24, in Salt Lake City from Oct. 9 to 11.

Congress’ failure to enact PBM reforms for Americans in Medicare and Medicaid and for their pharmacies is nothing short of a wasted opportunity, pharmacy groups said.

Pharmacies across the country have been significantly impacted by the disruption caused by the cyberattack on Change Healthcare, NACDS said.

NACDS’ second commitment—which was jointly submitted with the Milken Institute—was highlighted at the White House Challenge celebration event.